Infection Can Lead to False Negatives for Cerebrospinal Fluid β-2 Transferrin
By LabMedica International staff writers Posted on 21 Oct 2014 |
![Image: Scanning Electron Micrograph of Streptococcus pneumoniae by R. Facklam, J. Carr. Cerebrospinal fluid (CSF) β-2 transferrin detection decreases after inoculation with live or ciprofloxacin-inactived S. pneumoniae. This may be due to passive adsorption via distinctive features of the S. pneumoniae cell wall not present in the other bacterial species examined (Photo courtesy of MicrobeWiki and the CDC – [US] Centers for Disease Control and Prevention). Image: Scanning Electron Micrograph of Streptococcus pneumoniae by R. Facklam, J. Carr. Cerebrospinal fluid (CSF) β-2 transferrin detection decreases after inoculation with live or ciprofloxacin-inactived S. pneumoniae. This may be due to passive adsorption via distinctive features of the S. pneumoniae cell wall not present in the other bacterial species examined (Photo courtesy of MicrobeWiki and the CDC – [US] Centers for Disease Control and Prevention).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2014-10-21/MMS-117.jpg)
Image: Scanning Electron Micrograph of Streptococcus pneumoniae by R. Facklam, J. Carr. Cerebrospinal fluid (CSF) β-2 transferrin detection decreases after inoculation with live or ciprofloxacin-inactived S. pneumoniae. This may be due to passive adsorption via distinctive features of the S. pneumoniae cell wall not present in the other bacterial species examined (Photo courtesy of MicrobeWiki and the CDC – [US] Centers for Disease Control and Prevention).
Researchers have found that the presence of Streptococcus pneumoniae in cerebrospinal fluid (CSF) can lead to false-negative β-2 transferrin (β2TRNSF) test results and misdiagnosis that may detrimentally affect healthcare decisions for patients.
Free passage of bacterial flora from the nasal cavity and paranasal sinuses through a CSF fistula into the cranium may pose increased risk for meningitis and encephalitis. Thus, early diagnosis and treatment of CSF leakage could decrease the risk of a lethal infection. Although β2TRNSF is a highly reliable marker for diagnosing cases of CSF leakage (even in CSF contaminated with blood or other secretions)—it has not been examined in the presence of central nervous system bacterial infection.
In a prospective analysis, a team led by Nir Hirshoren, MD, at the Hebrew University School of Medicine–Hadassah Medical Center (Jerusalem, Israel) examined β2TRNSFdetection in artificially contaminated CSF as a research model. Sterile (tested for sterility) CSF was drawn from 9 prospectively-recruited neurosurgical patients. CSF samples were contaminated in vitro by controlled spiking with bacteria, chosen for ability to cause meningeal neurosurgical-related infections: Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus (MSSA), Staphylococcus epidermidis, or Pseudomonas aeruginosa.
β2TRNSF analysis was performed using qualitative immunoblotting electrophoresis and quantitative enzyme-linked immunosorbent assay (ELISA). Two time points were examined, following immediate inoculation (t0 ) and following an overnight incubation (t18 ), over various bacterial-load concentrations. In this study, only S. pneumoniae was observed to significantly affect β2TRNSF detection. At both the t0 and t18 time points following S. pneumoniae inoculation, β2TRNSF was not detected when immunoblotting electrophoresis was used; quantitative analysis using ELISA demonstrated significant β2TRNSF concentration decrease.
A secondary objective of the study was to explore whether the disappearance of β2TRNSF in the assays is due to a passive or active mechanism. The researchers suspected that in some cases of bacterial infections, β2TRNSF might be adsorbed, degraded, or consumed by bacteria. CSF inoculated with S. pneumoniae was also examined in the presence of the non-cell-wall antibiotic ciprofloxacin, which led to the same results. Since β2TRNSF detection decreased also with inactivated (i.e. + ciprofloxacin) S. pneumoniae, a passive process was suggested, possibly due to adsorption via distinctive features of the S. pneumoniae cell wall not present in the other species examined.
The authors note that although the study was limited by a small sample number (n=9), potential bias was largely overcome by exploring different bacterial loads, examining diverse clinical bacterial species, and using two reliable assays. Further investigation in the clinical setting is needed, however the results indicate that, in the presence of a S. pneumoniae cerebral nervous system infection, using a β2TRNSF test for CFS leak detection may be deceiving and should be interpreted cautiously.
The authors further caution that the importance of β2TRNSF assays is limited to borderline, clinical-uncertainty cases. In other cases, a β2TRNSF negative result may not change a clinical decision regardless of CSF S. pneumoniae presence, and appropriate imaging modalities and surgery may be warranted anyway.
The study was reported by Korem M. et al. in the journal Laryngoscope, September 29, 2014, online ahead of print.
Related Links:
Hebrew University School of Medicine – Hadassah Medical Center
Hebrew University Hadassah Medical School
Free passage of bacterial flora from the nasal cavity and paranasal sinuses through a CSF fistula into the cranium may pose increased risk for meningitis and encephalitis. Thus, early diagnosis and treatment of CSF leakage could decrease the risk of a lethal infection. Although β2TRNSF is a highly reliable marker for diagnosing cases of CSF leakage (even in CSF contaminated with blood or other secretions)—it has not been examined in the presence of central nervous system bacterial infection.
In a prospective analysis, a team led by Nir Hirshoren, MD, at the Hebrew University School of Medicine–Hadassah Medical Center (Jerusalem, Israel) examined β2TRNSFdetection in artificially contaminated CSF as a research model. Sterile (tested for sterility) CSF was drawn from 9 prospectively-recruited neurosurgical patients. CSF samples were contaminated in vitro by controlled spiking with bacteria, chosen for ability to cause meningeal neurosurgical-related infections: Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus (MSSA), Staphylococcus epidermidis, or Pseudomonas aeruginosa.
β2TRNSF analysis was performed using qualitative immunoblotting electrophoresis and quantitative enzyme-linked immunosorbent assay (ELISA). Two time points were examined, following immediate inoculation (t0 ) and following an overnight incubation (t18 ), over various bacterial-load concentrations. In this study, only S. pneumoniae was observed to significantly affect β2TRNSF detection. At both the t0 and t18 time points following S. pneumoniae inoculation, β2TRNSF was not detected when immunoblotting electrophoresis was used; quantitative analysis using ELISA demonstrated significant β2TRNSF concentration decrease.
A secondary objective of the study was to explore whether the disappearance of β2TRNSF in the assays is due to a passive or active mechanism. The researchers suspected that in some cases of bacterial infections, β2TRNSF might be adsorbed, degraded, or consumed by bacteria. CSF inoculated with S. pneumoniae was also examined in the presence of the non-cell-wall antibiotic ciprofloxacin, which led to the same results. Since β2TRNSF detection decreased also with inactivated (i.e. + ciprofloxacin) S. pneumoniae, a passive process was suggested, possibly due to adsorption via distinctive features of the S. pneumoniae cell wall not present in the other species examined.
The authors note that although the study was limited by a small sample number (n=9), potential bias was largely overcome by exploring different bacterial loads, examining diverse clinical bacterial species, and using two reliable assays. Further investigation in the clinical setting is needed, however the results indicate that, in the presence of a S. pneumoniae cerebral nervous system infection, using a β2TRNSF test for CFS leak detection may be deceiving and should be interpreted cautiously.
The authors further caution that the importance of β2TRNSF assays is limited to borderline, clinical-uncertainty cases. In other cases, a β2TRNSF negative result may not change a clinical decision regardless of CSF S. pneumoniae presence, and appropriate imaging modalities and surgery may be warranted anyway.
The study was reported by Korem M. et al. in the journal Laryngoscope, September 29, 2014, online ahead of print.
Related Links:
Hebrew University School of Medicine – Hadassah Medical Center
Hebrew University Hadassah Medical School
Latest Microbiology News
- Rapid UTI Test Cuts Detection Time from 3 days to 45 Minutes
- POC STI Test Shortens Time from ED Arrival to Test Results
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
Channels
Clinical Chemistry
view channel![Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF) Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-27/98234491_m_normal_none.jpg)
New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more![Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT) Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-10/MIT-Printed-Ion-01-press_0.jpg)
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more![Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University) Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-03-14/Spinning-Glowing (1).jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more![Image: The new versatile assay has the ability to measure both total and bioavailable cortisol from serum (Photo courtesy of Aarhus University) Image: The new versatile assay has the ability to measure both total and bioavailable cortisol from serum (Photo courtesy of Aarhus University)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-03-04/ac3c04435_0004.jpg)
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel![Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell) Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-17/landau_cfdna-cover-0-01.jpg)
Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods
Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more![Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics) Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-14/2024_Doctor-Holding-Kit.jpg)
Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection
Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more![Image: The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test runs on the cobas liat system (Photo courtesy of Roche) Image: The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test runs on the cobas liat system (Photo courtesy of Roche)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-13/image-media-info-cobas-liat-system-tube.jpg)
Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes
The U.S. Centers for Disease Control and Prevention (CDC) has reported that respiratory diseases in the United States reached high levels during the recent autumn and winter seasons, with SARS-CoV-2 leading... Read more![Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock) Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-12/AdobeStock_480745598 (1).jpeg)
First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening
Current prostate cancer (PCa) screening protocols typically begin with prostate-specific antigen (PSA) testing, which, if elevated, may lead to further assessment using multiparametric magnetic resonance... Read moreHematology
view channel![Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia) Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-09/C3_DBS_Website.2.jpg)
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more![Image: The Procleix ArboPlex Assay has received the CE mark (Photo courtesy of Grifols) Image: The Procleix ArboPlex Assay has received the CE mark (Photo courtesy of Grifols)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-08/donor-testing-1.jpg)
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more![Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health) Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-03-20/news-7.jpg)
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more![Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health) Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-02-08/inserting-hb-variant-cartridge.jpg)
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel![Image: The AI tool predicts whether someone’s cancer will respond to immune checkpoint inhibitors (Photo courtesy of National Cancer Institute) Image: The AI tool predicts whether someone’s cancer will respond to immune checkpoint inhibitors (Photo courtesy of National Cancer Institute)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-05/Surgical oncology 43 (1).jpg)
AI Tool Predicts Cancer Patients’ Response to Immunotherapy
Immune checkpoint inhibitors are a form of immunotherapy drug that enables immune cells to target and destroy cancer cells. At present, the Food and Drug Administration has approved two predictive biomarkers... Read more![Image: Initially aimed at children with high-risk cancers, ZERO now includes all young cancer patients in Australia (Photo courtesy of Zero Childhood Cancer) Image: Initially aimed at children with high-risk cancers, ZERO now includes all young cancer patients in Australia (Photo courtesy of Zero Childhood Cancer)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-03/906uv0fs34hr.jpg)
Molecular Profiling Improves Diagnosis for Children with High Risk Cancers
Cancer remains the leading cause of disease-related death among children in most developed nations, and approximately one-fourth of these patients are diagnosed with aggressive, high-risk, or relapsed... Read morePathology
view channel![Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock) Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-14/shutterstock_447424987.jpg)
New Technique Reveals Earliest Signs of Genetic Mutations
Mutations are alterations in the molecular "letters" that constitute the DNA code, which serves as the blueprint for all living cells. While some of these changes may be inconsequential, others can lead... Read more![Image: Diff-Quik stained smear from lung FNAB (Photo courtesy of Guoping Cai, Darin Dolezal, Ivana Kholová) Image: Diff-Quik stained smear from lung FNAB (Photo courtesy of Guoping Cai, Darin Dolezal, Ivana Kholová)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-13/Low-Res_jctp-23-68-g005.jpg)
New WHO Reporting System for Lung Cytopathology to Enhance Diagnostic Accuracy
Lung cancer continues to be the most common cause of cancer-related deaths worldwide and ranks as the second most frequently diagnosed cancer in both men and women. The role of lung cytopathology, which... Read more![Image: Three of 46 histomorphological phenotype clusters in small block tiles identified by AI from images of cancerous lung tissue (Photo courtesy of Dr. N. Coudray/NYU Grossman School of Medicine) Image: Three of 46 histomorphological phenotype clusters in small block tiles identified by AI from images of cancerous lung tissue (Photo courtesy of Dr. N. Coudray/NYU Grossman School of Medicine)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-12/inline_Untitled-3.jpg)
Self-Taught AI Tool Diagnoses and Predicts Severity of Common Lung Cancer
A computer program powered by artificial intelligence (AI) and trained on nearly half a million tissue images can effectively diagnose cases of adenocarcinoma, the most prevalent type of lung cancer.... Read more![Image: The new AI-powered statistics method has the potential to improve tissue and disease research (Photo courtesy of 123RF) Image: The new AI-powered statistics method has the potential to improve tissue and disease research (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-11/17907939_m_normal_none_1.jpg)
Novel AI-Powered Method for Tissue Analysis Improves Understanding of Disease Pathology
Scientists at Brown University (Providence, RI, USA) and the University of Michigan (Ann Arbor, MI, USA) have created a groundbreaking computational technique to examine complex tissue data, potentially... Read moreTechnology
view channel![Image: Illustration of the microneedle patch (Photo courtesy of Karolinska Institutet) Image: Illustration of the microneedle patch (Photo courtesy of Karolinska Institutet)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-05/plaster_custom20240529112158.jpg)
Microneedle Patch Detects Skin Cancer Early
Wearable bioelectronics has emerged as a significant innovation in healthcare, especially in the field of biosensing, providing a new method to monitor individual health for both diagnostic and therapeutic purposes.... Read more![Image: The nanopore optofluidic chip used in the new diagnostic system (Photo courtesy of UC Santa Cruz) Image: The nanopore optofluidic chip used in the new diagnostic system (Photo courtesy of UC Santa Cruz)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-09/new-diagnostic-tool-ac.jpg)
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read moreIndustry
view channel![Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche) Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-28/download.jpg)
Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing
Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more![Image: Scientists will evaluate new blood-based biomarkers using highly sensitive technology (Photo courtesy of 123RF) Image: Scientists will evaluate new blood-based biomarkers using highly sensitive technology (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-13/103048801_m_normal_none.jpg)
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more![Image: Beckman Coulter is now an authorized distributor of the MeMed Key immunoassay system and MeMed BV assay (Photo courtesy of Beckman Coulter) Image: Beckman Coulter is now an authorized distributor of the MeMed Key immunoassay system and MeMed BV assay (Photo courtesy of Beckman Coulter)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-09/PR_partnership_with_Beckman_Coulter_v1_2.jpg)
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more![Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF) Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-01/130140677_m_normal_none (1)_1.jpg)